DJ-1, elevated in cancers with poor prognosis and in advanced mastocytosis (shown here), has been implicated in cell-resistance to stress and anticancer drugs and thus it represents a potential target to weaken malignant cell advantage [10, 62, 63]. This evidence concerns the gene PARK7 and mastocytosis.